Filing Details
- Accession Number:
- 0000919574-15-008551
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-12-07 10:54:56
- Reporting Period:
- 2015-12-03
- Filing Date:
- 2015-12-07
- Accepted Time:
- 2015-12-07 10:54:56
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1327467 | Celator Pharmaceuticals Inc | CPXX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1576113 | D Scott Morenstein | C/O Caxton Alternative Management Lp 1330 Sixth Avenue, 20Th Floor New York NY 10019 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-12-03 | 5,000 | $1.87 | 6,277 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- This constitutes the weighted average purchase price. The prices range from $1.85 to $1.8693. The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- These securities are owned by Scott D. Morenstein, who is the Reporting Person. The 1,123,612 shares of common stock previously reported on the Reporting Person's Form 4 are no longer being included because the Reporting Person does not have beneficial ownership of these securities.
Billionaire Hedge Funds
